Showing results (1481-1490 of 5,060) with videos related to

Sort By:
Pageof 506
Multiple Sclerosis and Related Disorders|December 22, 2019
Tumefactive rebound of multiple sclerosis after the short-term cessation of fingolimod: A case reportFereshteh Ashtari, Mohammad Ali Sahraian, Marjan Oustad, et al.
Multiple Sclerosis and Related Disorders|December 23, 2019
Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumabTjalf Ziemssen, Michael Lang, Björn Tackenberg, et al.
Multiple Sclerosis and Related Disorders|December 24, 2019
Thalamo-cortical dysfunction contributes to fatigability in multiple sclerosis patients: A neurophysiological studyFioravante Capone, Francesco Motolese, Mariagrazia Rossi, et al.
Multiple Sclerosis and Related Disorders|December 18, 2019
Disease activity impacts disability progression in primary progressive multiple sclerosisM Marrodan, C Bensi, A Pappolla, et al.
Multiple Sclerosis and Related Disorders|December 20, 2019
Antigen-shift in varicella-zoster virus-specific T-cell immunity over the course of Fingolimod-treatment in relapse-remitting multiple sclerosis patientsSarah Matko, Katja Akgün, Torsten Tonn, et al.
Multiple Sclerosis and Related Disorders|December 14, 2019
Effects of Mindfulness-based interventions on physical symptoms in people with multiple sclerosis - a systematic review and meta-analysisRobert Simpson, Sharon Simpson, Nitish Ramparsad, et al.
Multiple Sclerosis and Related Disorders|February 24, 2018
A case of dextrocardia following maternal exposure to generic Fingolimod during the first trimester of pregnancySamira Navardi, Mohammad Ali Sahraian
Multiple Sclerosis and Related Disorders|February 19, 2018
The interplay of multiple sclerosis and menstrual cycle: Which one affects the other one?Omid Mirmosayyeb, Shervin Badihian, Navid Manouchehri, et al.
Multiple Sclerosis and Related Disorders|February 13, 2018
Fingolimod reduces the clinical expression of active demyelinating lesions in MSElisabetta Signoriello, Doriana Landi, Fabrizia Monteleone, et al.
Multiple Sclerosis and Related Disorders|February 13, 2018
Early relapse after RTX initiation in a patient with NMO/MS overlap syndrome: How long to conclude to a failure treatment?Elisabeth Maillart, Anaïs Lippi, Catherine Lubetzki, et al.
Pageof 506